Glucometer is a medical device that determines the approximate concentration of glucose in the blood.
Growing Prevalence of Chronic Diseases
According to the data published by National Library of Medicine in 2019, it has been reported that out of the total sample population, 13.7% were found to be affected with Type 2 Diabetes Mellitus (T2DM). The prevalence of T2DM increased sharply over successive age groups in both men and women. The prevalence of type 2 diabetes has been found to increase gradually with increasing BMI, especially in women (~20%, 37%, and 44%, respectively), while, in men it increased sharply (from 25% to ~50%) until a BMI of 29.9; it then decreased drastically (to ~24%) for a BMI of ≥30. Approximately 85% of men with type 2 diabetes were physically inactive, while her 97% of women with type 2 diabetes were physically inactive.
Download Free Sample ReportTechnological Advancements
Increasing prevalence of diabetes in Israel is leading to various technological advancements in the healthcare system of the country. Combo Glucometer (CoG) is the first non-invasive product which has been made commercial in the country that can be used for glucose monitoring. While using Combo Glucometer, the user only needs to place a finger in the device, which assesses reflected light from tissue via a digital image sensor and then employs proprietary algorithms to measure blood glucose levels. Moreover, GlucoTrack is another device developed by U.S.–Israeli company which can monitor blood sugar levels through a combination of ultrasonic, electromagnetic, and thermal waves. Better and more accurate diabetic care in healthcare centers is assisting patients, which is expected to bolster the growth of Israel glucometer market in the forecast period.
Rise in Geriatric Population
In the same year, 41% of senior citizens were 75 years of age.
Growing Prevalence of Obesity
According to the report published by Jewish News Syndicate (JNS) in 2023, it was found that 55% of men and 41% of women are overweight. A new study released by Israel’s Central Bureau of Statistics revealed that approximately half of Israelis over the age of 20 are overweight. Moreover, 54 percent of Arabs were found to be overweight, as compared to 46 percent of Jews.
Recent Developments
- InAugust 2021, HAGAR, an Israeli health technology company and developer of GWave,the world's first non-invasive continuous blood glucose monitoring system thatuses RF waves to measure blood glucose levels, received an investment of USD17.1 million from Columbia Pacific. The funds will be used to complete hisupcoming FDA-approved clinical trials and international patents.
- InOctober 2022, Dexcom introduced the Dexcom G7, a next-generation continuousglucose monitor (CGM), for diabetics two years of age and above. Dexcom G7 madean improvement on Dexcom continuous glucose monitoring (CGM) by adding newfeatures such as 60% smaller and discreet all-in-one wearable than any otherCGM on the market, with the fastest 30-minute sensor warm-up.
- InJune 2020, Tandem Diabetes Care and Abbott announced a collaboration to developand commercialize an integrated solution for diabetes care. These productscombine Abbott's continuous glucose monitoring technology with Tandem'sbreakthrough insulin delivery device to improve glycemic control in diabetics.
Israel glucometer market is segmented based on product type, technique, type, distribution channel, end source, company, and region. In terms of product type, the glucometer market is categorized into self glucose monitoring glucometers and continuous glucose monitoring glucometers. Based on, technique, market is divided into invasive and non-invasive. On the basis of type, glucometer market is segmented into wearable and non-wearable
Market Players
Cnoga Medical Ltd., F. Hoffmann-La Roche AG, Medtronic, Inc., Dexcom, Inc., DarioHealth Crop., Tandem Diabetes Care, Inc., Abbott Laboratories, and Dreamed Diabetes Ltd.
Attribute | Details |
Base Year | 2022 |
Historic Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024-2028 |
Quantitative Units | Revenue in USD Million, Volume in Tons and CAGR for 2018-2022 and 2023-2028 |
Report Coverage | Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends |
Segments Covered | Product Type Technique Type Distribution Channel End User |
Regional Scope | The Mediterranean Coastal Plain, The Central Hills, The Jordan Rift Valley, and The Negev Desert |
Key Companies Profiled | Cnoga Medical Ltd., F. Hoffmann-La Roche AG, Medtronic, Inc., Dexcom, Inc., DarioHealth Crop., Tandem Diabetes Care, Inc., Abbott Laboratories, and Dreamed Diabetes Ltd. |
Customization Scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and Purchase Options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |